Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Immunol Rev. 2019 Sep;291(1):134–153. doi: 10.1111/imr.12796

FIGURE 8. Checkpoint blockade and CAR-T cells and Tonic signals?

FIGURE 8.

Checkpoint blockade in the form of anti-CTLA4 or anti-PD1 as well as generation or CAR-T cells to fight tumors may lead to increased tonic mTORC1 signaling in T cells. Questions such as the impact of T cell therapy approaches on mTOR signaling in T cells will be important to address.